CCM
PFE icon

Capstone Capital Management’s Pfizer PFE Stock Holding History

Capstone Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Sell
14,840
-14,829
-50% -$388K 0.16% 144
2026
Q1 		$833K Buy
+29,669
New +$790K 0.84% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capstone Capital Management's PFE Position: Q2 2026 in Review

Capstone Capital Management reduced its Pfizer (PFE) stake by 50% in Q2 2026, selling an estimated $388K and leaving 14,840 shares worth $357K. The position accounts for 0.16% of the portfolio, ranked #144.

Capstone Capital Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $833K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capstone Capital Management held 14,840 shares of Pfizer worth $357K as of Q2 2026.
  • Capstone Capital Management sold 14,829 Pfizer shares in Q2 2026, an estimated $388K.
  • Pfizer made up 0.16% of Capstone Capital Management's portfolio in Q2 2026, its #144 holding.
  • Capstone Capital Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Capstone Capital Management's Pfizer position peaked at $833K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capstone Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.